Is the US prepared to deal with another pandemic or widespread health crisis?

Leans no

No, the US is not fully prepared for another pandemic or major widespread health crisis, though it is better positioned in some technical areas than before COVID-19. Assessments from bipartisan commissions, the Government Accountability Office (GAO), CDC, WHO-linked evaluations, and experts consistently describe a mixed picture: meaningful progress in stockpiles, surveillance, data systems, and some medical countermeasures (MCMs), offset by persistent gaps in leadership/coordination, sustained funding, state/local capacity, workforce, supply chains, and political/societal factors.[1][2]

Progress Since COVID-19

The US has taken concrete steps informed by COVID-19 lessons:

•Strategic National Stockpile (SNS): Significantly restocked. Reports indicate roughly 70 times the pre-pandemic N95 respirators, 34 times the gloves, 50 times the isolation gowns, and 10 times the ventilators. It has supported responses to H5N1, mpox, and other incidents by deploying PPE, antivirals, vaccines, and other supplies.[3]

•Surveillance and data: Electronic case reporting expanded dramatically (from under 200 healthcare facilities pre-pandemic to over 45,000–48,000 by late 2024). Syndromic surveillance covers most hospital EDs. CDC launched platforms for real-time data integration, forecasting/outbreak analytics (e.g., Center for Forecasting and Outbreak Analytics), and improved respiratory illness tracking.[4]

•Organizational and policy changes: Creation of the permanent White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023 for coordination. CDC structural reforms aimed at reducing silos, improving communications, lab quality, and public-private “warm base” partnerships for rapid test development/surge capacity. Updated biodefense strategies and playbooks exist. Investments advanced MCM R&D (vaccines, therapeutics, diagnostics) via BARDA and others, with approvals and stockpiling for threats like mpox.[3][3]

•Global and other efforts: Expanded Global Health Security partnerships, contributions to international funds/responses, and dual-use research oversight updates. The US historically ranks near the top of the Global Health Security (GHS) Index (e.g., high scores around 83+). A 2024 Joint External Evaluation (JEE) of IHR core capacities was completed, noting strengths while recommending improvements.[5][6]

These enhance detection speed, MCM availability for known threats, and basic response logistics compared to early 2020.

Persistent Gaps and Vulnerabilities

Independent reviews highlight that progress is incomplete and fragile:

•Leadership, coordination, and governance: The Bipartisan Commission on Biodefense’s 2024 National Blueprint for Biodefense states the nation “remains dangerously vulnerable,” that previous recommendations were not fully implemented (contributing to COVID’s toll of over 1 million US deaths), and that “immediate action” is needed across leadership, intelligence, science/tech, preparedness, detection, and response. Fragmented authorities, federal-state tensions, and unclear roles persist. GAO has repeatedly flagged HHS leadership/coordination of public health emergencies as high-risk, with hundreds of open COVID-related recommendations (over 200 as of mid-2024 across agencies).[1][2][1]

•Funding and sustainability: COVID supplemental funds have largely expired. Public health and SNS budgets face shortfalls relative to requirements (e.g., PHEMCE estimates higher needs for MCMs). Workforce shortages (public health, healthcare burnout/exodus), aging infrastructure, and proposed or enacted cuts raise concerns. Attention and investment have waned as the acute crisis faded.[7][8]

•Detection, testing, and early response: Recent threats like H5N1 (avian flu in cattle/poultry with some human cases) and mpox revealed delays in testing scale-up, surveillance (especially animal-human interface), coordination between agencies (e.g., HHS/USDA), and aggressive containment. Experts note insufficient broad-spectrum antivirals and rapid MCM platforms for novel pathogens.[7][9]

•State/local/tribal/territorial (SLTT) capacity and equity: Uneven preparedness; JEE and other reviews urge extending robust capabilities downward and addressing gaps. Supply chains remain vulnerable to disruption; domestic manufacturing of PPE/critical supplies needs further strengthening. Healthcare system strain capacity for surges is limited.

•Societal and other factors: Eroded trust in public health/institutions, misinformation, political polarization, and healthcare inequities hindered COVID response and could recur. Broader issues like hospital capacity, primary care access, and social determinants affect resilience. Global preparedness has also stagnated or declined in key areas per some WHO-linked assessments.[8][10]

GAO lessons emphasize better advance planning (roles, exercises, capabilities), partner collaboration, clear communications, data sharing, integrity controls for relief programs, leveraging existing systems, and flexibilities (e.g., telehealth). Many recommendations remain unimplemented.[2]

Bottom Line and Outlook

The US has stronger stockpiles, data tools, some MCM pipelines, and institutional memory than in 2019, enabling faster initial responses to contained or moderate threats (as seen with mpox elements or respiratory seasons). However, for a severe, novel, highly transmissible pathogen with high mortality—or concurrent crises—it is not adequately prepared. Structural fragmentation, inconsistent funding/political will, local capacity gaps, and incomplete lesson implementation leave major vulnerabilities. Experts and commissions warn that without sustained, bipartisan investment in core public health infrastructure, leadership clarity, One Health approaches (human-animal-environment), domestic production, R&D for platform technologies (e.g., 100-day vaccines), and trust-building, outcomes could again be suboptimal.[1]

Preparedness is a continuous process, not a destination. Ongoing monitoring of threats like H5N1, exercises, full implementation of open recommendations, and stable multi-year funding would improve readiness. Assessments evolve with new data, administrations, and budgets; current consensus from nonpartisan and bipartisan sources is that significant work remains.

Citations (10)

1biodefensecommission.orgNonprofits and think tanks
https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Assessments from bipartisan commissions, the Government Accountability Office (GAO), CDC, WHO-linked evaluations, and experts consistently describe a mixed picture: meaningful progress in stockpiles, surveillance, data systems, and some medical countermeasures (MCMs), offset by persistent gaps in…”
evidence, official document, points to no. Claim: Bipartisan Commission on Biodefense says the nation remains dangerously vulnerable and past recommendations were not fully implemented.
2gao.govGovernment
https://www.gao.gov/products/gao-24-107175
Backs: “Assessments from bipartisan commissions, the Government Accountability Office (GAO), CDC, WHO-linked evaluations, and experts consistently describe a mixed picture: meaningful progress in stockpiles, surveillance, data systems, and some medical countermeasures (MCMs), offset by persistent gaps in…”
evidence, official document, points to no. Claim: GAO flags HHS leadership and coordination of public health emergencies as high-risk, with many open COVID-related recommendations.
3archives.govGovernment
https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “It has supported responses to H5N1, mpox, and other incidents by deploying PPE, antivirals, vaccines, and other supplies.”
statistic, official document, points to yes. Claim: Strategic National Stockpile restocked (70x N95s, 10x ventilators), OPPR created, and countermeasure investments advanced.
4cdc.govGovernment
https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “CDC launched platforms for real-time data integration, forecasting/outbreak analytics (e.g., Center for Forecasting and Outbreak Analytics), and improved respiratory illness tracking.”
statistic, official document, points to yes. Claim: Electronic case reporting expanded from under 200 to over 45,000 facilities; CDC data and forecasting platforms improved.
5who.intGovernment
https://iris.who.int/bitstream/handle/10665/380155/9789240105409-eng.pdf?sequence=1sask
Backs: “A 2024 Joint External Evaluation (JEE) of IHR core capacities was completed, noting strengths while recommending improvements.”
evidence, official document, neutral. Claim: 2024 Joint External Evaluation of IHR capacities noted strengths while recommending improvements.
6ghsindex.orgData and tools
https://ghsindex.org/country/united-states/
Backs: “A 2024 Joint External Evaluation (JEE) of IHR core capacities was completed, noting strengths while recommending improvements.”
statistic, data page, points to yes. Claim: The US ranks near the top of the Global Health Security Index, with scores around 83+.
7nejm.orgAcademic
https://www.nejm.org/doi/full/10.1056/NEJMp2406427
Backs: “Attention and investment have waned as the acute crisis faded.”
evidence, article, points to no. Claim: Funding shortfalls, workforce issues, and H5N1/mpox responses revealed testing and coordination delays.
8stimson.orgNonprofits and think tanks
https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Attention and investment have waned as the acute crisis faded.”
evidence, article, points to no. Claim: Attention and investment have waned; societal factors and stagnating preparedness remain concerns.
9ft.comNews and mediaquality 0.93
https://www.ft.com/content/2ff195fc-b89d-401d-acfa-800aff68bb80
Backs: “Experts note insufficient broad-spectrum antivirals and rapid MCM platforms for novel pathogens.”
evidence, article, points to no. Claim: H5N1 response showed gaps in surveillance and a lack of broad-spectrum antivirals and rapid countermeasure platforms.
10forbes.comNews and mediaquality 0.83
https://www.forbes.com/sites/maryroeloffs/2026/05/18/world-isnt-ready-for-another-pandemic-and-moving-in-the-wrong-direction-who-report-says/
Backs: “Global preparedness has also stagnated or declined in key areas per some WHO-linked assessments.”
evidence, article, points to no. Claim: WHO-linked report says global preparedness has stagnated or declined, and the world is not ready for another pandemic.